
oct pm et
summari provid health insur program servic primarili government-sponsor
health care program particularli medicaid medicar
price-to-earnings oper ep
success record expand health
insur coverag new state
government-sponsor plan individu exchang
plan accomplish leverag
acquisit intern expans view strategi
posit also see risk potenti
state reduc medicaid reimburs amid budget
review unexpect increas medic cost
oct ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
past perform indic futur perform reli upon
analysi prepar equiti analyst
oct pm stock trade
star recommend
recent chang strong buy
buy target price
recent chang
highlight section stock
report updat accordingli
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
rais target
ep estim premium
peer averag justifi
expect materi
above-averag growth next two year
due major invest made
strong environ medicaid insur
rais ep estim
follow success
acquisit health net fuel
ep compound-annual-growth-rate
juli acquir lead new
york medicaid insur fide
think larg acquisit
conserv financ continu
run strong growth largest
medicaid insur think well
posit due growth total state tax
revenu yoy
accord censu
state medicaid budget pressur
slow revenu growth view /colin
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview centen corpor provid program servic govern sponsor
healthcar program particularli medicaid medicar focus under-insur uninsur
compani provid member-focus servic locally-bas staff assist access
care coordin referr relat health social servic address member concern
question also provid educ outreach program inform assist member access
compani oper two segment manag specialti servic manag
segment provid health plan coverag individu govern subsid program includ
medicaid state children health insur program chip long term care foster dual
elig individu dual supplement secur incom program also known age blind
disabl program collect abd
june total membership million member million member
year earlier compani membership breakdown follow medicaid -- million member
million non-risk commerci --
compani health plan provid variou servic primari specialti physician care
inpati outpati hospit care emerg urgent care prenat care laboratori x-ray
servic home health durabl medic equip behavior health substanc abus servic
prescript limit over-the-count drug specialti pharmaci therapi social work servic
consult drug util review formulari rebat manag on-line drug manag tool
mail order pharmaci servic home deliveri servic analyt clinic consult well patient
physician intervent acariahealth offer special care manag servic complex
diseas enhanc patient care offer collabor provid captur
relev data measur patient outcom
triag well diseas manag servic compani network featur rang
servic level care help peopl mental ill reach recoveri well goal
util telephon health work/lif balanc coach in-hom on-line interact informat
process deliv clinic outcom enhanc patient-provid satisfact compani offer
telehealth servic member reach bilingu custom servic repres nurs staff
provid health educ triag advic offer continu access health plan function
impact major develop complet numer acquisit help supplement
organ growth march complet acquisit health net billion think
strengthen presenc western state particular california medicaid program
countri largest million member well program arizona oregon
washington juli acquir fide billion fide base new york
sale billion new york nation second largest medicaid membership fide
member june
financi trend sale driven acquisit expans new state grown
billion billion repres three-year compound annual growth rate compound-annual-growth-rate
adjust ep increas repres three-year compound-annual-growth-rate
medic loss ratio rang rose
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
lt debt capit
analysi stock current worth base
figur base fiscal year-end price
cfra proprietari quantit model suggest
slightli under-valued
growth rate averag
neutral sinc octob technic indic
neutral
lt debt capit
return equiti
net life insur
balanc sheet data million
equival
return revenu
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
basi point versu
think trend continu growth
enrolle often aid employ ad
new hire company-sponsor health plan
view gain may harder
come economi approach full
employ repeal individu
mandat may also begin contribut slower
enrolle growth take effect
bright side think improv econom
growth mostli off-set flat enrolle growth
insur abl negoti decent
premium increas strong economi
medicaid insur particular well
posit view growth total state
tax revenu acceler
accord
 censu data think medicaid insur
negoti better price state
budget pressur slow revenu
growth also insur larg medicar
busi like still see strong enrolle
growth due estim new babi
boomer becom elig medicar everi
 manag health index
rose vs rise
composit index year-to-d octob
manag health index risen
vs rise
fundament outlook manag health
care sub-industri next month
posit think largest driver
industri earn growth next year
deflationari environ
gener drug price help contain medic
cost price gain improv economi
margin improv vertic integr
pharmaci benefit manag pbm
posit view temper lower growth
total enrolle expect come
think deflat gener drug price
improv medic loss ratio
health insur expect continu
next year averag price gener
drug drop rate
higher last year estim
contribut health insur see
manag growth medic cost per insur
around year-over-year
compar favor premium per insur
estim grew around
period aid improv price negoti
stronger economi
anoth factor like help contain
medic cost trend toward integr
health insur pbm pend
combin aetna
express script latest
iter trend plan
launch in-hous pbm joint ventur
begin januari
think move provid solid margin
improv continu entiti
suspect pbm captur materi rebat drug
maker alway pass payer
health care consum
moder posit outlook manag
care sub-industri slow total enrolle
growth see estim
year-over-year growth total enrolle slow
base index
five-year market price perform oct
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
rais target peer
ep estim set ep vs
estim sale rose health benefit ratio rose
partli end cost share reduct subsidi
enrol exceed make biggest compani public
exchang enter kansa missouri nevada expand six
state sign-up total
membership grew /jeffrey loo cfa
rais target price in-lin
peer forward ep estim ep vs
ahead estim keep ep estim
sale rose driven increas member
million member encourag growth rate howev warn
presid trump decis end cost share reduct csr payment
could advers impact ep expect continu share
volatil csr payment remain signific congression debat
rais target below-p
forward ep estim ep vs
ahead estim rais ep estim sale
rose increas membership million member health
benefit ratio improv encourag robust
membership growth remain cautiou congression republican continu
work healthcar bill continu signific uncertainti
believ medicaid cut remain target republican /jeffrey loo
analyst research note compani news
strong buy buy rais target
ep estim premium peer averag
justifi expect materi above-averag growth
next two year due major invest made strong
environ medicaid insur rais ep estim
follow success acquisit
health net fuel ep compound-annual-growth-rate
juli acquir lead new york medicaid insur fide
think larg acquisit conserv financ
continu run strong growth largest medicaid insur
think well posit due growth total state tax revenu
yoy accord censu
data price negoti abil improv state medicaid budget
pressur slow revenu growth view /colin scarola
buy hold rais target price
ep estim price-to-earnings premium peer-averag
expect growth next two year materi outpac
peer due major invest made rais ep estim
initi juli acquir lead
new york medicaid insur fide follow
integr health net acquir march help
increas ep year end june base
success histori confid realiz estim
cost synergi year two fide acquisit also think
leader medic cost contain long-term due
strateg invest health care technolog compani made
includ rxadvanc leader cloud-bas pbm technolog interpreta
clinic genom data analysi firm /colin scarola
rais target price
slightli peer forward ep estim
lower margin peer averag due signific medicaid
membership ep vs ahead estim
rais ep estim ep estim
sale rose driven increas commerci
unit commerci member rose member overal membership
member million health benefit ratio hbr improv
basi point compar year ago worsen
hbr partli impact retroact minimum medic loss
ratio chang california medicaid program complet acquisit
fide juli see fide contribut billion
revenu million ebitda annual run-rat /jeffrey loo
et cfra keep hold opinion share corpor
keep target slightli peer
ep estim revis partli due
delay complet pend acquisit fide
expect juli make contribut state
new york paid five year part initi provid high
qualiti health care vulner popul contribut
expens sg ep vs ahead
estim estim ep higher due delay financ
pend fide deal revenu rose driven membership gain
growth health insur marketplac expans
new program sever state health benefit ratio compar
aid lower medic cost medicaid busi
reinstat health insur fee sg cost rose
sale /jeffrey loo cfa
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
